Research analysts at StockNews.com started coverage on shares of Evogene (NASDAQ:EVGN – Get Free Report) in a research note issued on Saturday. The brokerage set a “sell” rating on the biotechnology company’s stock. Evogene Stock Up 1.3 % Shares of EVGN stock opened at $0.66 on Friday. Evogene has a 12 month low of $0.45 […]